Attenuation of learned helplessness in rats after transplant of adrenal medulla into the spinal cord

European Psychiatry

Volumn 11, Issue 5, 1996, Pages 249-253

  Tejedor Real, P ^a   Mico J A ^a   Corbalan, J P ^a   Ruz Franzi, I ^a   Gonzalez Darder J M ^a   Gibert Rahola, J ^a  

^a UNIVERSITY OF CÁDIZ   (Spain)

Author keywords

adrenal medullary transplant; depression; learned helplessness; naloxone; opioid peptides; rat

Indexed keywords

NALOXONE; OPIATE PEPTIDE;

ADRENAL MEDULLA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DEPRESSION; HELPLESSNESS; LEARNING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSPLANTATION;

EID: 0029778440     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/0924-9338(96)82331-5     Document Type: Article

References (35)

1. Anisman H, Suissa A, Sklar LS. Escape deficits induced by uncontrollable stress: antagonism by dopamine and norepinephrine agonists. Behav Neural Biol 1980;28:3444-74
2. Bommer N, Herz A. Neuropeptides and other secretagogues in bovine chromaffin cells: their effect on opioid peptide metabolism. Neuropeptides 1989;13:2443-51
3. Devoize JL, Rigal F, Eschalier A, Trolese JF, Renoux M. Influence of naloxone on antidepressant drug effect in the forced-swimming test in mice. Psychopharmacology 1984;84:71-5
4. Extein I, Pottash ALC, Gold MS. A possible opioid receptor dysfunction in some depressive disorders. In: Verebey K, ed. Opioids in Mental Illness: Theory, Clinical Observations, and Treatment Possibilities. New York: The New York Academy of Sciences, 1982:108-12
5. Gaumann DM, Yaksh TL. Effects and opiate antagonists on adrenal release of neuropeptides in cats. Peptides 1988;9: 393-405
6. Guide for the Care and Use of Laboratory Animals. US Department of Health, Education and Welfare, Public health service National Institute of Health, DHEW Publication N0 (NIH) 78-23, Revised 1978
7. Hamon M, Gozlan H, Bourgoin S et al. Opioid receptors and neuropeptides in the CNS in rats treated chronically with amoxapine or amitriptyline. Neuropharmacology 1987; 26:531-9
8. Isemberg KE, Cicero T. Possible involvement of opiate receptors in the pharmacological profiles of antidepressant compounds. Eur J Pharmacol 1984;103:57-63
9. Kuramoto H, Kondo H, Fujita T. Calcitonine gene-related peptide (CGPR)-like immunoreactivity in scattered chromaffin cells and nerve fibers in the adrenal gland. Cell Tissue Res 1987;247:309-15
10. Linberg I, Yang HYT. Distribution of met(5)-enk-arg(6)-gly(7)-leu(8)-immunoreactive peptides in rat brain: presence of multiple molecular form. Brain Res 1984; 299:73-8
11. Livett BG, Dean DM, Whelan LG, Udenfriend S, Rossier J. Co-release of enkephalin and catecholamines from cultured adrenal chromaffin cells. Nature 1981;289:317-9
12. Martin P, Soubrié P, Simon P. Noradrenergic and opioid mediation of tricyclic-induced reversal of escape deficits caused by inescapable shock pretreatment in rats. Psychopharmacology (Berlin) 1986a;90:90-4
13. Martin P, Soubrié P, Simon P. Shuttle-box deficits induced by inescapable shocks in rats: Reversal by the beta-adrenoceptor stimulants clenbuteron and salbutamol. Pharmacol Biochem Behav 1986b;24:177-81
14. Naber D. Opioids on the etiology and treatment of psychiatric disorders. In: Herz A, ed. Opioid II. Berlin, Heidelberg: Springer-Verlag, 1993;781-801
15. Ortega JD, Sagen J. Pharmacologic characterization of opioid peptide release from chromaffin cell transplants using a brain slice superfusion method. J Exp Brain Res 1993;95: 381-7
16. Ortega-Alvaro A, Gibert-Rahola J, Chover AJ, Tejedro-Real P, Casa, J, Micó JA. Effect of amitriptyline on the analgesia induced by adrenal medullary tissue transplanted in the rat spinal subarachnoid space as measured by an experimental model of acute pain. Exp Neurol 1994;130:9-14
17. Petty F, Sherman AD. Reversal of learned helplessness by imipramine. Community Psychopharmacol 1980;3:371-3
18. Ruz-Franzi JI, González-Darder JM. Study of the analgesic effects of the implant of adrenal medullary into the subarachnoid space in rats. Acta Neurochir (Wein) 1991;52 (suppl):39-41
19. Sagen J, Pappas GD, Pollard HB. Adrenal medullary tissue transplants in rat spinal cord reduce pain sensitivity. Brain Res 1986a;384-9
20. Sagen J, Pappas GD, Pollard HB. Analgesia induced by isolated bovine chromaffin cells implanted in rat spinal cord. Proc Natl Acad Sci USA 1986b;83:7522
21. Sagen J, Kemmler E. Increased levels of met-enkephalin-like immunoreactivity in the spinal cord CSF of rats with adrenal medullary transplant. Brain Res 1989;502:1-10
22. Sagen J, Wang H. Prolonged analgesia by enkephalinase inhibition in rats with spinal cord adrenal medullary transplant. Eur J Pharmacol 1990;179:427-33
23. Sagen J, Sortwell CE, Pappas GD. Monoaminergic neural transplant prevent learned helplessness in a rat depression model. Biol Psychiatry 1990;28:1037-47
24. Sagen J, Kemmler JE, Wang H. Adrenal medullary transplants increase spinal cord cerebrospinal fluid catecholamine levels and reduce pain sensitivity. J Neurochem 1991;56: 623-7
25. Sawynok J, Pinsky C, LaBella FS. Minireview on the specifity of naloxone as an opiate antagonist. Life Sci 1979;25: 1621-32
26. Sherman AD, Petty F. Additivity of neurochemical changes in learned helplessness and imipramine. Behav Neural Biol 1982;35:344-53
27. Tejedor-Real P, Mico JA, Maldonado R, Roques BP, Gibert-Rahola J. Effect of mixed (RB 38A) and selective (RB 38B) inhibitors of enkephalin degrading enzymes on a model of depression in the rat. Biol Psychiatry 1993;34:100-7
28. Tejedor-Real P, Micó JA, Maldonado R, Roques B, Gibert-Rahola J. Implication of endogenous opioid system in the learned helplessness model of depression. Pharmacol Biochem Behav 1995;52:145-52
29. Tejedor-Real P, Romero P, Micó JA, Gibert-Rahola J. Efecto del NPY en el modelo de depresón "learned helplessness". Posible interacción con el sistema noradrenérgico. Anales Psiquiatría Biológica 1994;10(suppl 1):49
30. Vaquero J, Arias A, Oya Santiago, Zurita M. Chromaffin allografts into arachnoid of spinal cord reduce basal pain responses in rats. Neuroreport 1991;2:149-51
31. Widerlöv MD, Heilig MD, Bjartell A, Ekman R. Involvement of Neuropeptide Y and Delta-Sleep-Inducing Peptide in Neuropsychiatric Illness. In: Nemeroff CB, ed. Neuropeptides and Psychiatric Disorders. Washington DC: American Psychiatric Press, Inc, 1991;227-60
32. Willner P. The validity of animal models of depression. Psychopharmacology 1984;83:1-16
33. Willner P. Behavioral Models in Psychopharmacology, Theoretical, Industrial and Clinical Perspectives. Cambridge: Cambridge University Press, 1990
34. Willson SP, Chang J, Viveros OH. Proportional secretion of opioid peptides and catecholamines form adrenal cromaffin cells in culture. J Neurosci 1982;2:1150-6
35. Yang HT, Hexum T, Costa E. Opioid peptides in adrenal gland. Life Sci 1980;27:1119-25